I must say that I was worried that BLT would suffer the same fate as Calimmune. They were forced to screen only one participant at a time, meaning a delay of six weeks every time one failed to qualify, resulting in a delay of six months overall.
So, in a way, this small delay is good news.
Thanks mickchop for the article regarding RA Capital. Good to know that the best performing biotech hedge fund in the world has such faith in BLT.
I must say that I was worried that BLT would suffer the same...
Add to My Watchlist
What is My Watchlist?